EUVIMEDEUVIMED entdecken
Crossref

Two-Year Clinical Outcomes after Ultrathin-Strut Polymer-Free Sirolimus- and Probucol-Eluting Stent versus Durable-Polymer Everolimus-Eluting Stent Placement

Takuya Tsujimura, Takayuki Ishihara, Masaharu Masuda, Shin Okamoto, Kiyonori Nanto, Yasuhiro Matsuda, Yosuke Hata, Hiroyuki Uematsu, Sho Nakao, Masaya Kusuda, Wataru Ariyasu, Toshiaki Mano

Angioscopy and Cardiovascular Imaging · 2026 · 1 (1) · n/a

DOI: 10.15791/aci.oa.26-001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angioscopy and Cardiovascular Imaging, 2026. Verfasst von Takuya Tsujimura und 11 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The ultrathin-strut, polymer-free sirolimus- and probucol-eluting stent (PF-SES; Coroflex ISAR NEO; B. Braun, Melsungen, Germany) was developed to promote rapid arterial healing compared with durable-polymer drug-eluting stents (DESs). However, its long-term clinical performance remains unclear. This study aimed to evaluate the 2-year clinical outcomes following percutaneous coronary intervention (PCI) with PF-SES versus a durable-polymer everolimus-eluting stent (DP-EES; Xience).Methods and Results: This single-center, retrospective observational study included 2916 lesions from 2090 patients with coronary artery disease who underwent successful PCI with either PF-SES (472 lesions, 333 patients) or DP-EES (2444 lesions, 1757 patients) between July 2011 and December 2022. Two-year outcomes, including major adverse cardiac events (MACEs; composite of cardiac death, myocardial infarction, or target vessel revascularization) and target lesion revascularization (TLR), were compared. Multivariate Cox proportional hazards model and inverse probability weighting (IPW) analyses were used to evaluate the impact of the PF-SES on outcomes. The 2-year cumulative incidences of MACE (PF-SES: 9.4% vs. DP-EES: 11.7%, P = 0.28) and TLR (PF-SES: 4.6% vs. DP-EES: 5.0%, P = 0.76) were comparable. Multivariate and IPW analyses confirmed no significant association between PF-SES use and MACE (P = 0.88 and P = 0.87) or TLR (P = 0.78 and P = 0.95). The interaction analysis showed that the effect of PF-SES on the risk of TLR did not differ significantly across subgroups.

Conclusion

PF-SES implantation was associated with comparable 2-year safety and efficacy outcomes to DP-EES.

Zitieren

APA

Tsujimura, T., Ishihara, T., Masuda, M., Okamoto, S., Nanto, K., Matsuda, Y., Hata, Y., Uematsu, H., Nakao, S., Kusuda, M., Ariyasu, W., & Mano, T. (2026). Two-Year Clinical Outcomes after Ultrathin-Strut Polymer-Free Sirolimus- and Probucol-Eluting Stent versus Durable-Polymer Everolimus-Eluting Stent Placement. Angioscopy and Cardiovascular Imaging, 1(1), n/a. https://doi.org/10.15791/aci.oa.26-001

Vancouver

Tsujimura T, Ishihara T, Masuda M, Okamoto S, Nanto K, Matsuda Y, et al. Two-Year Clinical Outcomes after Ultrathin-Strut Polymer-Free Sirolimus- and Probucol-Eluting Stent versus Durable-Polymer Everolimus-Eluting Stent Placement. Angioscopy and Cardiovascular Imaging. 2026;1(1):n/a. doi:10.15791/aci.oa.26-001

BibTeX
@article{Tsujimura2026,
  author = {Tsujimura, Takuya and Ishihara, Takayuki and Masuda, Masaharu and Okamoto, Shin and Nanto, Kiyonori and Matsuda, Yasuhiro and Hata, Yosuke and Uematsu, Hiroyuki and Nakao, Sho and Kusuda, Masaya and Ariyasu, Wataru and Mano, Toshiaki},
  title = {Two-Year Clinical Outcomes after Ultrathin-Strut Polymer-Free Sirolimus- and Probucol-Eluting Stent versus Durable-Polymer Everolimus-Eluting Stent Placement},
  journal = {Angioscopy and Cardiovascular Imaging},
  year = {2026},
  volume = {1},
  number = {1},
  pages = {n/a},
  doi = {10.15791/aci.oa.26-001}
}
Kostenlos starten →